BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1156 related articles for article (PubMed ID: 3511090)

  • 1. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
    Hoelzer DR; Dalsky GP; Clutter WE; Shah SD; Holloszy JO; Cryer PE
    J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon, not insulin, may play a secondary role in defense against hypoglycemia during exercise.
    Tuttle KR; Marker JC; Dalsky GP; Schwartz NS; Shah SD; Clutter WE; Holloszy JO; Cryer PE
    Am J Physiol; 1988 Jun; 254(6 Pt 1):E713-9. PubMed ID: 3287952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholamines in prevention of hypoglycemia during exercise in humans.
    Marker JC; Hirsch IB; Smith LJ; Parvin CA; Holloszy JO; Cryer PE
    Am J Physiol; 1991 May; 260(5 Pt 1):E705-12. PubMed ID: 1674642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting.
    Boyle PJ; Shah SD; Cryer PE
    Am J Physiol; 1989 May; 256(5 Pt 1):E651-61. PubMed ID: 2655471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin and glucagon in prevention of hypoglycemia during exercise in humans.
    Hirsch IB; Marker JC; Smith LJ; Spina RJ; Parvin CA; Holloszy JO; Cryer PE
    Am J Physiol; 1991 May; 260(5 Pt 1):E695-704. PubMed ID: 2035626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence against important catecholamine compensation for absent glucagon counterregulation.
    De Feo P; Perriello G; Torlone E; Fanelli C; Ventura MM; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
    Am J Physiol; 1991 Feb; 260(2 Pt 1):E203-12. PubMed ID: 1996624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of cortisol to glucose counterregulation in humans.
    De Feo P; Perriello G; Torlone E; Ventura MM; Fanelli C; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
    Am J Physiol; 1989 Jul; 257(1 Pt 1):E35-42. PubMed ID: 2665516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemia-induced autonomic failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation.
    Rattarasarn C; Dagogo-Jack S; Zachwieja JJ; Cryer PE
    Diabetes; 1994 Jun; 43(6):809-18. PubMed ID: 8194668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epinephrine's effect on metabolic rate is independent of changes in plasma insulin or glucagon.
    Staten MA; Matthews DE; Cryer PE; Bier DM
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E185-92. PubMed ID: 2569829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms.
    Towler DA; Havlin CE; Craft S; Cryer P
    Diabetes; 1993 Dec; 42(12):1791-8. PubMed ID: 8243825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms.
    Schwartz NS; Clutter WE; Shah SD; Cryer PE
    J Clin Invest; 1987 Mar; 79(3):777-81. PubMed ID: 3546378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pancreatic-adrenocortical-pituitary clamp technique for study of counterregulation in humans.
    De Feo P; Perriello G; Ventura MM; Brunetti P; Santeusanio F; Gerich JE; Bolli GB
    Am J Physiol; 1987 Apr; 252(4 Pt 1):E565-70. PubMed ID: 2882686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postexercise dose-response relationship between plasma glucose and insulin secretion.
    Mikines KJ; Farrell PA; Sonne B; Tronier B; Galbo H
    J Appl Physiol (1985); 1988 Mar; 64(3):988-99. PubMed ID: 3284873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoinsulinemia is not critical to glucose recovery from hypoglycemia in humans.
    Heller SR; Cryer PE
    Am J Physiol; 1991 Jul; 261(1 Pt 1):E41-8. PubMed ID: 1858873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of overt hypoglycemia during exercise: stimulation of endogenous glucose production independent of hepatic catecholamine action and changes in pancreatic hormone concentration.
    Coker RH; Koyama Y; Denny JC; Camacho RC; Lacy DB; Wasserman DH
    Diabetes; 2002 May; 51(5):1310-8. PubMed ID: 11978626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans.
    Berk MA; Clutter WE; Skor D; Shah SD; Gingerich RP; Parvin CA; Cryer PE
    J Clin Invest; 1985 Jun; 75(6):1842-51. PubMed ID: 3891786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual dimorphism in counterregulatory responses to hypoglycemia after antecedent exercise.
    Galassetti P; Neill AR; Tate D; Ertl AC; Wasserman DH; Davis SN
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3516-24. PubMed ID: 11502773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.